Tekmira provides update on TKM-ebola phase I clinical hold
Tekmira announced an update on the TKM-Ebola Phase I clinical hold. The Company has received the clinical hold letter from the FDA and is preparing a Complete Response to the Agency. The Company anticipates this matter will be resolved by Q4, 2014. July 21, 2014